Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
59
BKTI Quote, Financials, Valuation and Earnings
Last price:
$29.40
Seasonality move
:
12.18%
Day range:
$29.53 - $31.67
52-week range:
$11.67 - $38.70
Dividend yield:
0%
P/E ratio:
22.36x
P/S ratio:
1.48x
P/B ratio:
4.23x
Volume:
20.5K
Avg. volume:
21.2K
1-year change:
140.72%
Market cap:
$110M
Revenue:
$74.1M
EPS (TTM):
$1.38
BK Technologies Number of Institutional Trades
BK Technologies Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$62.8M
(Last 6 Months)
Current Institutional Ownership Percentage
43.41%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$71.1M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BK Technologies Institutional Ownership
-
What Percentage Of BKTI Is Owned by Institutions?
43.41% of BKTI is owned by institutions.
-
How Many Institutions Own BKTI Shares?
BK Technologies stock is owned by 69 institutional shareholders at this time.
-
Have Institutions Been Buying BKTI Stock?
Yes, institutions have bought 1.4M shares of BKTI in the last quarter.
-
Have Institutions Been Selling BKTI Stock?
Yes, institutions have sold 1.4M shares of BKTI over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
